All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Occult HBV Infection-32763811

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	32763811	A128V	S	S	Occult HBV Infection	G I C L	View
2	32763811	A159V	S	S	Occult HBV Infection	G I C L	View
3	32763811	F134V	S	S	Occult HBV Infection	G I C L	View
4	32763811	M103T	S	S	Occult HBV Infection	G I C L	View
5	32763811	M133T	S	S	Occult HBV Infection	G I C L	View
6	32763811	P120A	S	S	Occult HBV Infection	G I C L	View
7	32763811	P120T	S	S	Occult HBV Infection	G I C L	View
8	32763811	P127L	S	S	Occult HBV Infection	G I C L	View
9	32763811	P127S	S	S	Occult HBV Infection	G I C L	View
10	32763811	P127T	S	S	Occult HBV Infection	G I C L	View
11	32763811	Q101H	S	S	Occult HBV Infection	G I C L	View
12	32763811	Q101K	S	S	Occult HBV Infection	G I C L	View
13	32763811	Q101R	S	S	Occult HBV Infection	G I C L	View
14	32763811	Q129P	S	S	Occult HBV Infection	G I C L	View
15	32763811	S114A	S	S	Occult HBV Infection	G I C L	View
16	32763811	S117T	S	S	Occult HBV Infection	G I C L	View
17	32763811	T115N	S	S	Occult HBV Infection	G I C L	View
18	32763811	T118R	S	S	Occult HBV Infection	G I C L	View
19	32763811	T118S	S	S	Occult HBV Infection	G I C L	View
20	32763811	T123N	S	S	Occult HBV Infection	G I C L	View
21	32763811	T123S	S	S	Occult HBV Infection	G I C L	View
22	32763811	T126A	S	S	Occult HBV Infection	G I C L	View
23	32763811	T126N	S	S	Occult HBV Infection	G I C L	View
24	32763811	T126S	S	S	Occult HBV Infection	G I C L	View
25	32763811	T131N	S	S	Occult HBV Infection	G I C L	View
26	32763811	T140I	S	S	Occult HBV Infection	G I C L	View
27	32763811	A159G	S	S	Occult HBV Infection	G I C L	View
28	32763811	M133I	S	S	Occult HBV Infection	G I C L	View
29	32763811	S143T	S	S	Occult HBV Infection	G C L	View
30	32763811	V168A	S	S	Occult HBV Infection	G I C L	View
31	32763811	T118K	S	S	Occult HBV Infection	G I C L	View
32	32763811	C121R	S	S	Occult HBV Infection	G C L	View
33	32763811	D144E	S	S	Occult HBV Infection	G C L	View
34	32763811	F134L	S	S	Occult HBV Infection	G C L	View
35	32763811	K122R	S	S	Occult HBV Infection	G I C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.